Featured Research

from universities, journals, and other organizations

Invisibility cloak for immune cells keeps system healthy

Date:
June 25, 2014
Source:
ETH Zürich
Summary:
The human immune system is very complex. A large number of different cells with various functions ensure that invading microorganisms such as viruses or bacteria can quickly be rendered innocuous and the entire organism stays healthy. Researchers have now discovered what keeps certain cells of the immune system healthy: concealing their stress with a camouflage cloak that renders them invisible to the "killer" cells.

The human immune system is very complex. A large number of different cells with various functions ensure that invading microorganisms such as viruses or bacteria can quickly be rendered innocuous and the entire organism stays healthy.

The immune system also includes natural killer cells (NK cells), which recognize and eliminate tumour or virus-infected cells. NK cells therefore combat the body's own stressed cells to prevent them from becoming a potential hazard. However, this bears its risks. Other immune cells, the specific killer cells, which are also known as CD8+ T cells and multiply prodigiously and mature in response to an infection, can also exhibit stress symptoms and thereby potentially end up on the NK cells' hit list.

Interferon acting as a camouflaging hood

Researchers from immune biology professor Annette Oxenius's group have now discovered what keeps NK cells from killing off their "colleagues from the other department" of the immune system: healthy CD8+ cells are able to detect the immune messenger substance type 1 interferon, which binds to specific receptors on the surface of these immune cells and thereby conceals their stress. In other words, it acts as a camouflage cloak that renders them invisible to the NK cells. If the T cells lack the docking site for type 1 interferon, however, they are hunted down by the NK cells and exterminated.

The researchers discovered this using mice which they infected with two model viruses. If the animals' CD8+ T cells lacked these interferon receptors, not only did the NK cells eliminate the virus-infected cells, but also the immune cells that were supposed take action, thereby weakening the antiviral immune response.

Cell-death signal trained

The researchers studied exactly how the mechanism works using mice whose CD8+ T cells did not have any type 1 interferon receptors and in whom they also depleted the NK cells. If no natural killers were present, the T cells multiplied, matured and developed despite the lack of interferon detection. Moreover, the ETH-Zurich immune biologists discovered that these sensorless T cells increasingly formed an "identification tag" on their surfaces, which triggered the lethal effect of the NK cells as soon as they came into contact with them. Thus, the expression of this "stress tag" is suppressed by interferon binding to and signalling via the interferon receptors on T cells. If this signalling is prevented because the receptor is lacking, the cell expresses large amounts of these stress molecules.

Mechanism for autoimmune diseases?

So far, it is unclear whether the same mechanism also exists in humans. However, the basic processes that the human immune system uses to protect its T cells against an attack from natural killer cells might well be comparable. On the one hand, the researchers now understand which mechanisms the stressed T cells need to protect themselves against NK cells. On the other hand, this insight enables new hypotheses to be formulated. For instance, it is conceivable that T cells activated in the absence of type 1 interferon reveal themselves as being "stressed" and are thus killed off. Such situations could arise during the activation of autoimmune reactive T cells, for instance, which normally occurs in absence of high concentrations of type 1 interferon. Oxenius and her team will test these exciting hypotheses with great interest over the next few years.


Story Source:

The above story is based on materials provided by ETH Zürich. Note: Materials may be edited for content and length.


Journal Reference:

  1. Josh Crouse, Gregor Bedenikovic, Melanie Wiesel, Mark Ibberson, Ioannis Xenarios, Dorothee Von Laer, Ulrich Kalinke, Eric Vivier, Stipan Jonjic, Annette Oxenius. Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1. Immunity, 2014; 40 (6): 961 DOI: 10.1016/j.immuni.2014.05.003

Cite This Page:

ETH Zürich. "Invisibility cloak for immune cells keeps system healthy." ScienceDaily. ScienceDaily, 25 June 2014. <www.sciencedaily.com/releases/2014/06/140625101348.htm>.
ETH Zürich. (2014, June 25). Invisibility cloak for immune cells keeps system healthy. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/06/140625101348.htm
ETH Zürich. "Invisibility cloak for immune cells keeps system healthy." ScienceDaily. www.sciencedaily.com/releases/2014/06/140625101348.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins